114 related articles for article (PubMed ID: 23408353)
1. Senescence in pancreatic carcinogenesis: from signalling to chromatin remodelling and epigenetics.
Singh SK; Ellenrieder V
Gut; 2013 Sep; 62(9):1364-72. PubMed ID: 23408353
[TBL] [Abstract][Full Text] [Related]
2. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
Qian J; Niu J; Li M; Chiao PJ; Tsao MS
Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
[TBL] [Abstract][Full Text] [Related]
3. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
4. Cooperativity of oncogenic K-ras and downregulated p16/INK4A in human pancreatic tumorigenesis.
Chang Z; Ju H; Ling J; Zhuang Z; Li Z; Wang H; Fleming JB; Freeman JW; Yu D; Huang P; Chiao PJ
PLoS One; 2014; 9(7):e101452. PubMed ID: 25029561
[TBL] [Abstract][Full Text] [Related]
5. [Alteration of the K-ras and p16/CDKN2 gene in endocrine pancreatic carcinomas].
Shirahama S; Matsuyoshi J; Yamamoto S; Tsukada Y
Nihon Rinsho; 2004 May; 62(5):889-93. PubMed ID: 15148814
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
7. Escape from premature senescence is not sufficient for oncogenic transformation by Ras.
Peeper DS; Dannenberg JH; Douma S; te Riele H; Bernards R
Nat Cell Biol; 2001 Feb; 3(2):198-203. PubMed ID: 11175753
[TBL] [Abstract][Full Text] [Related]
8. A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence.
Peeper DS; Shvarts A; Brummelkamp T; Douma S; Koh EY; Daley GQ; Bernards R
Nat Cell Biol; 2002 Feb; 4(2):148-53. PubMed ID: 11812999
[TBL] [Abstract][Full Text] [Related]
9. [Molecular diagnosis of pancreatic cancer].
Sugano K
Nihon Geka Gakkai Zasshi; 1997 Jul; 98(7):597-603. PubMed ID: 9276865
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster.
Cerny WL; Mangold KA; Scarpelli DG
Cancer Res; 1992 Aug; 52(16):4507-13. PubMed ID: 1643642
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention.
Atkinson SP; Keith WN
Expert Rev Mol Med; 2007 Mar; 9(7):1-26. PubMed ID: 17352843
[TBL] [Abstract][Full Text] [Related]
12. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma.
Dammann R; Schagdarsurengin U; Liu L; Otto N; Gimm O; Dralle H; Boehm BO; Pfeifer GP; Hoang-Vu C
Oncogene; 2003 Jun; 22(24):3806-12. PubMed ID: 12802288
[TBL] [Abstract][Full Text] [Related]
13. [Alterations of the p16 gene for the carcinogenesis in pancreas].
Wang C; Lu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Oct; 22(5):491-3. PubMed ID: 12903437
[TBL] [Abstract][Full Text] [Related]
14. The Roles of Chromatin Remodeling Genes in Pancreatic-Biliary Malignancies.
Luchini C; Nottegar A
Crit Rev Oncog; 2017; 22(5-6):471-479. PubMed ID: 29604925
[TBL] [Abstract][Full Text] [Related]
15. [Differential genetic pathway of duct and acinar carcinomas of the pancreas].
Tsutsumi M
Gan To Kagaku Ryoho; 2005 May; 32(5):593-8. PubMed ID: 15918556
[TBL] [Abstract][Full Text] [Related]
16. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Adsay NV; Basturk O; Cheng JD; Andea AA
Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479
[TBL] [Abstract][Full Text] [Related]
17. Oncogene-induced senescence as an initial barrier in lymphoma development.
Braig M; Lee S; Loddenkemper C; Rudolph C; Peters AH; Schlegelberger B; Stein H; Dörken B; Jenuwein T; Schmitt CA
Nature; 2005 Aug; 436(7051):660-5. PubMed ID: 16079837
[TBL] [Abstract][Full Text] [Related]
18. [Molecular pathways of pancreatic carcinogenesis].
Torrisani J; Buscail L
Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152
[TBL] [Abstract][Full Text] [Related]
19. Defects in TGF-beta signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras.
Tremain R; Marko M; Kinnimulki V; Ueno H; Bottinger E; Glick A
Oncogene; 2000 Mar; 19(13):1698-709. PubMed ID: 10763827
[TBL] [Abstract][Full Text] [Related]
20. Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
Fleming JB; Shen GL; Holloway SE; Davis M; Brekken RA
Mol Cancer Res; 2005 Jul; 3(7):413-23. PubMed ID: 16046552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
